Target intelligence / Profile preview

Zinc finger DHHC-type containing protein 24 (ZDHHC24)

Target
ZDHHC24
Molecular classification
Enzyme, Palmitoyltransferase, Zinc finger protein
01

Overview

Zinc finger DHHC-type containing protein 24 (ZDHHC24) is an enzyme that catalyzes the S-palmitoylation of proteins, a post-translational modification where palmitate is covalently attached to cysteine residues on substrate proteins[2]. ZDHHC24 is part of the large ZDHHC family of palmitoyltransferases that regulate protein trafficking, membrane localization, and stability. Its expression and function affect diverse cellular processes, and dysregulation is linked to cancer, especially lung adenocarcinoma, where ZDHHC24 serves as a poor prognostic marker and correlates with immune microenvironment alterations[1]. ZDHHC24 is also implicated in Bardet-Biedl syndrome[2]. There are currently no approved drugs targeting ZDHHC24 specifically, and existing inhibitors lack isoform selectivity, presenting both safety and efficacy challenges for therapeutic development targeting this enzyme[3][4].

Other names
Probable palmitoyltransferase ZDHHC24DHHC-24UNQ2528/PRO6027zinc finger DHHC domain-containing protein 24ZDHHC24
02

Mechanism of action

Inhibition of S-palmitoylation (by covalent binding to the active-site cysteine in ZDHHC enzymes, resulting in blocked enzymatic activity)[4]

03

Biological functions

Protein S-palmitoylation (protein-cysteine S-palmitoyltransferase activity)Protein targeting to membraneRegulation of protein localization, stability, and trafficking
04

Disease associations

CancerBardet-Biedl syndromeOther (implicated in neurodegeneration and metabolic disorders through dysregulated palmitoylation)
05

Safety considerations

Targeting ZDHHC enzymes carries risks of broad substrate effects and unintended consequences due to overlapping substrate specificity in the ZDHHC family[3][4]Inhibitors like 2-BP are non-specific, affecting all ZDHHC enzymes and potentially causing toxicity[4]
06

Interacting drugs

2-Bromopalmitate (2-BP, a pan-palmitoylation inhibitor, non-selective)[4]

2 more in the full profile.

07

Biomarkers

May act as a prognostic biomarker in lung adenocarcinoma (LUAD): high expression associated with poor survival and altered immune cell infiltration[1]

Beyond the preview

Go deeper on Zinc finger DHHC-type containing protein 24 (ZDHHC24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger DHHC-type containing protein 24 (ZDHHC24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call